An Unbiased View of Ximelagatran
Identify your collection: Title must be a lot less than characters Opt for a collection: Unable to load your assortment on account of an mistakeIn 2006, its producer AstraZeneca declared that it would not make an effort to current market ximelagatran soon after reports of hepatotoxicity (liver problems) for the duration of trials, and to discontinu